| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |